To our knowledge, this is the first large‐scale multicenter study to add neglected CA50 to the clinical diagnostic model of BTCs, which has good diagnostic value in distinguishing iCCA from HCC by combining CA50, CA19‐9, and AFP. The gene discussed is AFP; the disease is hepatocellular carcinoma.